Chemicals - Specialty · NYSE
Current Price
$106.35
Intrinsic Value
$120.13
+11.5% margin of safety
As of 2026-10-06, the base-case DCF model estimates the intrinsic value of Albemarle Corporation (ALB) at $120.13 per share, compared with a market price of $106.35, a margin of safety of +11.5%. The base case assumes 2.3% annual free cash flow growth and a 10.0% discount rate.
Across the sensitivity grid the estimate spans $89.1 to $156.5. Intrinsic value is an estimate built on assumptions, not a fact. A higher discount rate or slower growth pushes the estimate down, while stronger cash flow growth lifts it.
How the DCF works · Recalculate with your own assumptions · What is intrinsic value?
At $106.35, ALB trades about 11.5% below the base-case intrinsic value estimate. That is a real discount, but it stays short of the 30% margin of safety required before calling a stock undervalued.
COMPETITIVE MOAT
↑Proprietary Lithium Extraction Technology
Albemarle possesses unique, patented technologies for extracting lithium from brine resources. This provides a cost advantage and operational efficiency over competitors.
↑Long-Term Customer Contracts
The company secures significant revenue through multi-year supply agreements with major battery and automotive manufacturers. These contracts create customer stickiness and predictable demand.
↑Global Scale and Resource Access
Albemarle operates large-scale, low-cost lithium extraction facilities in key regions. This global footprint and access to prime resources are difficult for new entrants to replicate.
INVESTMENT RISKS
↓Project Execution and Ramp-Up Delays
Delays in bringing new lithium production capacity online can hinder sales volume growth and impact financial performance. This is critical for meeting expanding demand.
↓Geopolitical and Regulatory Environment
Operating in multiple countries exposes Albemarle to varying political risks and environmental regulations. Changes in these factors can affect operational costs and access to resources.
↓Intensifying Competition and New Entrants
The high demand for lithium attracts new players and existing competitors are expanding capacity. This can lead to increased price competition and market share erosion.
Base case
Intrinsic Value
$120.13
Margin of safety
+11.5%
Expected annual return
+2.5%
Base case assumptions: 2.3% annual growth, 10.0% discount rate, 9.34x exit multiple, 5 year projection. Data as of 2026-10-06.
This base case uses default assumptions and is not financial advice. The intrinsic value changes significantly when the growth rate or discount rate changes. Open the calculator to set your own assumptions and see the full sensitivity range.
Adjust the growth rate, discount rate, and exit multiple to see how the intrinsic value and margin of safety for Albemarle Corporation respond.
Open DCF Calculator for ALBAlbemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.
Revenue/Share (TTM)
$50.08
FCF/Share (TTM)
$11.38
ROIC (TTM)
3.3%
ROE (TTM)
2.3%
P/FCF
9.3x
EV/EBITDA
10.5x
FCF Yield
10.70%
Debt/Equity
0.19x
On a trailing twelve-month basis, ALB generates free cash flow per share of $11.38 alongside a ROIC of 3.3%, both central inputs for a DCF valuation. Its P/FCF ratio of 9.3x and FCF yield of 10.70% then frame how ALB is priced against peers on a cash flow basis.
Albemarle Corporation currently generates $11.38 in free cash flow per share. At the current price of $106.35, a DCF model would discount these cash flows at an appropriate WACC and apply a terminal growth rate to arrive at an intrinsic value. The result depends heavily on your growth and discount rate assumptions — a 1% change in WACC typically shifts the fair value estimate by 10-15%. In MiniValuator the model uses a single discount rate that you can edit directly, 10% by default, rather than a computed WACC.
ALB trades at a P/FCF ratio of 9.3x with a free cash flow yield of 10.70%. A low P/FCF means investors are paying less per dollar of free cash flow; whether that is cheap depends on the company's growth, cyclicality, and capital intensity. However, whether ALB is truly undervalued requires comparing the DCF intrinsic value to the current market price and evaluating whether the margin of safety is sufficient for your risk tolerance.
To perform a DCF valuation on Albemarle Corporation: (1) Start with the trailing free cash flow per share ($11.38) as the base, (2) project future FCF growth over 5-10 years based on Chemicals - Specialty industry trends and company fundamentals, (3) apply a discount rate (WACC) reflecting ALB's risk profile — with a debt-to-equity of 0.19x, capital structure is an important factor, and (4) add a terminal value for cash flows beyond the projection period.
DCF (Discounted Cash Flow) estimates what a company is worth today based on its future cash generation. For Albemarle Corporation, this means projecting how much free cash flow the company will produce over the next 5-10 years, shaped by Chemicals - Specialty trends, then discounting those amounts to today's dollars. ALB's ROIC of 3.3% means the company's return on invested capital sits below the level that typically clears its cost of capital.
WACC (Weighted Average Cost of Capital) is the discount rate in a DCF model — it reflects the minimum return investors require. For ALB, with a debt-to-equity ratio of 0.19x, the capital structure directly influences WACC. A 1% increase in WACC typically reduces the intrinsic value by 10-15%. At an EV/EBITDA of 10.5x, the market's implied discount rate can be reverse-engineered for comparison. In MiniValuator you set this discount rate yourself as a single editable number, 10% by default, instead of computing a formal WACC.
DCF and P/E value ALB with different methods and assumptions, so the two conclusions can differ. Compare the P/E fair value.
Price as of 2026-10-06. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.